A pilot study of a structured interview addressing sexual function in men with schizophrenia.
Twenty physically healthy men with schizophrenia responded to a 15-item questionnaire inquiring about their usual and their present (on medications) sexual functioning. Two summary measures of present impairment (the average of items 7-13 that detail the patients' specific complaints of impairment, and item 15, the interviewer's global judgment of impairment) were significantly correlated with each other and with the differences between usual and present reported frequencies of erection and masturbation. More severe impairment on these summary measures was significantly associated with greater biological evidence of dopamine blockade (more severe extrapyramidal side effects and higher serum prolactin levels).
Burke
M A
MA
Department of Psychiatry, Duke University Medical Center, Durham, NC.
McEvoy
J P
JP
Ritchie
J C
JC
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000175:diagnosis; D005476:Fluphenazine / Q000009:adverse effects / Q000627:therapeutic use; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D008418:Masturbation; D010410:Penile Erection / Q000187:drug effects; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis* / Q000188:drug therapy; D012565:Schizophrenic Psychology; D012725:Sexual Behavior / Q000187:drug effects; D011795:Surveys and Questionnaires
D006220:Haloperidol; D005476:Fluphenazine